Orchestra BioMed Holdings, Inc.
OBIO
$4.86
-$0.13-2.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.99% | -3.69% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.99% | -3.69% | |||
| Cost of Revenue | 6.52% | 4.55% | |||
| Gross Profit | 2.78% | -4.13% | |||
| SG&A Expenses | 13.31% | 0.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.01% | 1.89% | |||
| Operating Income | -5.10% | -2.15% | |||
| Income Before Tax | -7.57% | -3.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.57% | -3.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.57% | -3.24% | |||
| EBIT | -5.10% | -2.15% | |||
| EBITDA | -5.12% | -2.17% | |||
| EPS Basic | 20.86% | -2.81% | |||
| Normalized Basic EPS | 20.88% | -2.80% | |||
| EPS Diluted | 20.86% | -2.81% | |||
| Normalized Diluted EPS | 20.88% | -2.80% | |||
| Average Basic Shares Outstanding | 35.93% | 0.41% | |||
| Average Diluted Shares Outstanding | 35.93% | 0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||